A Pragmatic Randomised Clinical Trial of Nicotine Vaporisers added to Smoking Cessation Treatment for Priority Populations Living with Comorbidities [ 2017 - 2021 ]

Research Grant

[Cite as]

Researchers: A/Pr Coral Gartner (Principal investigator) ,  Dr Linda Cobiac Dr Peter Baker Prof Billie Bonevski Prof Jochen Mueller
View all 7 related researchers

Brief description Smoking is a leading cause of early death for people with certain health conditions because they are more likely to smoke and are also at greater risk of tobacco-related disease. This clinical trial will test whether encouraging people living with Hepatitis C Virus, people on opiate substitution therapy and people living with HIV who smoke to use nicotine vaporisers long-term, in addition to current smoking cessation treatments, will help them to stay abstinent from smoking.

Funding Amount $AUD 1,535,217.55

Funding Scheme Project Grants

Notes Standard Project Grant

Viewed: [[ro.stat.viewed]]